adialpharma.com (ADIL): Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan

Adial Pharmaceuticals (ADIL) maintains an environmental policy limited to basic waste disposal and energy saving within its laboratories. The stock price history allows for the tracking of EV/EBITDA, which currently stands at 0.00. The company's business moat relies on unique patents for combating alcoholism and lobbyist support under strict FDA oversight. Adial Pharmaceuticals (ADIL) currently generates no consistent profit, as its medications are still undergoing clinical trials.

ADIL Adial Pharmaceuticals, Inc.: Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan ing interval 23.11.2025 - 29.10.2026

adialpharma.com - rincian analitis lan metrik utama (ADIL)

- rega saiki lan proyeksi nilai saham:

Rega saham Adial Pharmaceuticals, Inc.|ADIL - Prakiraan konsensus analis

- data kapitalisasi bursa:

Nilai pasar Adial Pharmaceuticals, Inc.|ADIL - Nilai Dipunlarasaken Utang lan Kas

- indikator nilai buku ekuitas:

Aset Bersih saben Siji Saham Adial Pharmaceuticals|ADIL - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku adialpharma.com|ADIL - Total Aset Perusahaan

- informasi babagan utang lan solvabilitas:

Total Utang marang Modal Adial Pharmaceuticals|ADIL - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang modal Adial Pharmaceuticals, Inc.|ADIL - Gunggung kewajiban utang perusahaan|Utang-utang marang kapitalisasi buku Adial Pharmaceuticals, Inc.|ADIL - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Adial Pharmaceuticals|Indikator likuiditas cepet adialpharma.com

- data bathi bisnis lan rasio investasi:

ADIL - Bathi pungkasan|Bathi sing dikarepake Adial Pharmaceuticals|ADIL - Kapitalisasi marang bathi resik|Pangali Forward P/E Adial Pharmaceuticals, Inc.|ADIL - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA Adial Pharmaceuticals, Inc.|ADIL - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan Adial Pharmaceuticals|ADIL - Bathi saben saham sajroning taun lumaku|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan adialpharma.com|ADIL - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Adial Pharmaceuticals

Analisis komprehensif perusahaan:Adial ADIL

The EV/EBITDA ratio compares the total enterprise value of a business, including net debt, with its operating profit before depreciation and taxes. By analyzing the EV/EBITDA trajectory of a company, an investor identifies phases of asset overheating or undervaluation, minimizing the risks of emotional trading. For Adial Pharmaceuticals (ADIL), this metric is critical, as the dependence on AD04 patents renders future margins speculative.

Pesaing Adial Pharmaceuticals